Study: FDA finds competitive generic therapies launch faster than other generics
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationGenericsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsJoanne S. EglovitchApproval/marketing authorizationGenericsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)